These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22793666)

  • 1. Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury.
    Sharma AM; Li Y; Novalen M; Hayes MA; Uetrecht J
    Chem Res Toxicol; 2012 Aug; 25(8):1708-19. PubMed ID: 22793666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash.
    Chen J; Mannargudi BM; Xu L; Uetrecht J
    Chem Res Toxicol; 2008 Sep; 21(9):1862-70. PubMed ID: 18729332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine bioactivation and covalent binding in the skin.
    Sharma AM; Klarskov K; Uetrecht J
    Chem Res Toxicol; 2013 Mar; 26(3):410-21. PubMed ID: 23387501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash.
    Sharma AM; Novalen M; Tanino T; Uetrecht JP
    Chem Res Toxicol; 2013 May; 26(5):817-27. PubMed ID: 23590230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Chen Y; Fitch WL
    Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
    Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
    Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of danger signals in nevirapine-induced skin rash.
    Zhang X; Sharma AM; Uetrecht J
    Chem Res Toxicol; 2013 Sep; 26(9):1378-83. PubMed ID: 23947594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.
    Srivastava A; Lian LY; Maggs JL; Chaponda M; Pirmohamed M; Williams DP; Park BK
    Drug Metab Dispos; 2010 Jan; 38(1):122-32. PubMed ID: 19797610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine.
    Tateishi Y; Ohe T; Yasuda D; Takahashi K; Nakamura S; Kazuki Y; Mashino T
    Drug Metab Pharmacokinet; 2020 Apr; 35(2):238-243. PubMed ID: 32184040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death.
    Heck CJS; Seneviratne HK; Bumpus NN
    J Med Chem; 2020 Jun; 63(12):6561-6574. PubMed ID: 32065749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of Nevirapine Analogs To Reduce Metabolically Linked Hepatotoxicity: A Cautionary Tale of the Deuteration Approach.
    Kandel SE; Gracey EG; Lampe JN
    Chem Res Toxicol; 2023 Oct; 36(10):1631-1642. PubMed ID: 37769118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of carbon tetrachloride-induced hepatic injury on stereoselective N-demethylation of chlorpheniramine by rat hepatic cytochrome P450 2C11 isozyme].
    Nomura A; Sakurai E; Hikichi N
    Yakugaku Zasshi; 1998 Aug; 118(8):317-23. PubMed ID: 9739616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity.
    Walubo A; Barr S; Abraham AM
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):423-31. PubMed ID: 17003847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in utero and postnatal gavage studies).
    National Toxicology Program
    Natl Toxicol Program Genet Modif Model Rep; 2013 Oct; (16):1-236. PubMed ID: 24503698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine.
    Cho T; Hayes A; Henderson JT; Uetrecht J
    Toxicol Sci; 2024 Aug; 200(2):382-393. PubMed ID: 38767978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes.
    Mani C; Pearce R; Parkinson A; Kupfer D
    Carcinogenesis; 1994 Dec; 15(12):2715-20. PubMed ID: 8001226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation.
    Dekker SJ; Zhang Y; Vos JC; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2016 Dec; 29(12):2136-2144. PubMed ID: 27989146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R; Bhateria M; Singh R; Bhatta RS
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of quinone methide metabolites of dauricine in human liver microsomes and in rat bile.
    Wang Y; Zhong D; Chen X; Zheng J
    Chem Res Toxicol; 2009 May; 22(5):824-34. PubMed ID: 19358519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nevirapine-induced liver lipid-SER inclusions and other ultrastructural aberrations.
    Sastry J; Mohammed H; Campos MM; Uetrecht J; Abu-Asab M
    Ultrastruct Pathol; 2018; 42(2):108-115. PubMed ID: 29424579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.